Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 20 Cholinergic-Blocking Drugs.

Slides:



Advertisements
Similar presentations
Chapter 20 Cholinergic Drugs.
Advertisements

Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 19 Adrenergic-Blocking Drugs.
CNS STIMULANTS SAMUEL AGUAZIM. What is the definition of a CNS stimulant? A CNS stimulant is a drug that increases motor activity, causes excitement and.
Copyright © 2014 by Mosby, an imprint of Elsevier Inc.
Cholinergic-Blocking Drugs
Pharmacology-1 PHL 313 Parasympathetic Nervous System
Pharmacology-1 PHL 313 Parasympathetic Nervous System Third Lecture By Abdelkader Ashour, Ph.D. Phone:
ANTICHOLINERGIC DRUGS Pharmacology Department
1. 2 Cholinoceptor-Blocking Drugs Yacoub Irshaid MD, PhD, ABCP Department of Pharmacology.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 18 Autocoids and Antihistamines.
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 52 Antiemetic and Antinausea Drugs.
Chapter 5 Autonomic Drugs.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.
CHAPTER 21 Cholinergic-Blocking Drugs
Lecture 3 Autonomic Nervous System. Chapter 20 Autonomic Nervous System n n Central Nervous System (CNS) - Brain and spinal cord n n Peripheral Nervous.
Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 7 Anticholinergic (Parasympatholytic) Bronchodilators.
Parasympathetic agonist & antagonist
Autonomic Nervous System
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 18 Adrenergic Drugs.
Jacob Hummel M.D. Tulane University Anesthesiology.
ANTICHOLINERGIC DRUGS Prof. Alhaider Pharmacology Department Prof. Hanan Hagar Pharmacology Department.
Anticholinergic drugs Prof. Alhaider 1433 H Are drugs that block cholinergic receptors. Anticholinergic drugs.
DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM 10/8/2015Winter
ANTICHOLINERGIC DRUGS Prof. Alhaider Pharmacology Department Prof. Hanan Hagar Pharmacology Department.
Copyright © 2011 Delmar, Cengage Learning. ALL RIGHTS RESERVED. Chapter 13 Autonomic Nervous System Drugs.
Chapter 33 Agents Affecting the Autonomic Nervous System.
Slide 1 Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 13 Drugs Affecting the Autonomic Nervous System.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 17 Adrenergic Drugs.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 19 Cholinergic Drugs.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 53 Antiemetic and Antinausea Drugs.
Chapter 34 The Autonomic Nervous System. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Autonomic.
Cholinergic drugs.
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 20 Cholinergic Drugs.
Created by: Laura Runstrom and Kim Tran. Muscarinic Receptor Location M1M1 M2M2 M3M3 Salivary glands Uterus Heart Eyes Lungs Stomach Pancreas Lungs Salivary.
Cholinergic antagonists
ANTICHOLINERGIC DRUGS
ANTICHOLINERGIC DRUGS Prof. Alhaider Pharmacology Department Prof. Hanan Hagar Pharmacology Department.
ANTICHOLINESTERASES Acetylcholinesterase is an enzyme that specifically cleaves acetylcholine to acetate and choline. It is located both pre-and post-synaptically.
Drugs Affecting the Autonomic Nervous System
AUTONOMIC NERVOUS SYSTEM LECTURE 6 PHARMACOLOGY. Autonomic Pharmacology Autonomic Nervous System – This system is divided into two separate systems. –
Muscarinic antagonists:- Naturally occurring atropine & hyoscine, homatropine.
Drugs Used to Treat Gastroesophageal Reflux and Peptic Ulcer Diseases
Anticholinergic Drugs
Cholinergic antagonists Samuel Aguazim ( MD). What are cholinergic antagonists? Drugs that bind to cholinergic receptors ( muscarinic and/or nicotinic),
Cholinoceptor Blocking Agents Pawitra Pulbutr M.Sc. In Pharm (Pharmacology)
HuBio 543 September 24, 2007 Neil M. Nathanson K-536A, HSB Muscarinic Antagonists.
PHARMACOLOGY REVIEW. What is Pharmacology ? Pharmacology Pharmacokinetics Pharmacodynamics What the body does to drug What the drug does to body Pharmacotherapeutics.
Dr: Samah Gaafar Al-shaygi بسم الله الرحمن الرحيم.
Drugs Affecting Autonomic Nervous System 2. Drugs Affecting the Autonomic Nervous System Cholinergic Agents Cholinergic Blocking Agents.
Autonomic Nervous System Anticholinergic Drugs- 5
INDIRECT CHOLINOMIMETICS Prof. Hanan Hagar Pharmacology Department.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Adrenoceptors  The adrenergic receptors are classified into Two categories:
Copyright © 2016, 2013, 2010 by Saunders, an imprint of Elsevier Inc. All rights reserved. Chapter 14 Muscarinic Agonists and Antagonists.
Drugs Affecting the Autonomic Nervous System
Cholinergic-Blocking Drugs
Neuromuscular blockers
Autonomic NS 3.
Cholinergic Agent -A cholinergic drug is a drug that acts on the peripheral nervous system, the central nervous system, or both and enhances the effects.
Drugs Affecting Autonomic Nervous System 2
Anticholinergic Agents
Cholinergic Agents 10/01/1440 Saja Hamed, Ph.D.
Drugs for Autonomic Nervous System
Neurotransmitters SOMATIC NERVOUS SYSTEM Striated ACh muscle
Cholinergic Antagonist
Cholinergic Antagonist
Chapter 5 Autonomic Drugs.
Intro to Neuromuscular blocking agents
Neuromuscular blockers
Copyright © 2011 by Elsevier Inc. All rights reserved.
Cholinergic Blocking Drugs: Actions
Presentation transcript:

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 20 Cholinergic-Blocking Drugs

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Definition Drugs that block or inhibit the actions of acetylcholine (ACh) in the parasympathetic nervous system (PSNS) Also known as anticholinergics

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Mechanism of Action  Competitive antagonists  Compete with ACh  Block ACh at the muscarinic receptors in the PSNS  As a result, ACh is unable to bind to the receptor site and cause a cholinergic effect

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Mechanism of Action (cont’d) Once these drugs bind to receptors, they inhibit nerve transmission at these receptors

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.

Chemical Class NaturalSynthetic/Semisynthetic atropinebenztropineclidinium belladonnadicyclomineglycopyrrolate hyoscyaminehomatropineipratropium scopolamineisopropamide methscopolamine oxybutyninpropantheline tolterodinetrihexyphenidyl Many others

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Drug Effects  Cardiovascular  Small doses: decrease heart rate  Large doses: increase heart rate  CNS  Small doses: decrease muscle rigidity and tremors  Large doses: drowsiness, disorientation, hallucinations

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Drug Effects (cont’d)  Eye  Dilated pupils (mydriasis)  Decreased accommodation due to paralysis of ciliary muscles (cycloplegia)  Gastrointestinal  Relax smooth muscle tone of GI tract  Decrease intestinal and gastric secretions  Decrease motility and peristalsis

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Drug Effects (cont’d)  Genitourinary  Relaxed detrusor muscle  Increased constriction of internal sphincter  Result: urinary retention  Glandular  Decreased bronchial secretions, salivation, sweating

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Drug Effects (cont’d)  Respiratory  Decreased bronchial secretions  Dilated bronchial airways

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Indications: CNS  Decreased muscle rigidity and muscle tremors  Parkinson’s disease  Drug-induced extrapyramidal reactions

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Indications: Cardiovascular Affect the heart’s conduction system  Low doses: slow the heart rate  High doses: block inhibitory vagal effects on the SA and AV node pacemaker cells  Result: increased heart rate

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Indications: Atropine Used primarily for cardiovascular disorders  Diagnosis of sinus node dysfunction  Symptomatic second-degree heart block  Severe sinus bradycardia with hemodynamic compromise (advanced life support)

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Indications: Respiratory  Blocking the cholinergic stimulation of the PSNS allows unopposed action of the SNS  Results  Decreased secretions from nose, mouth, pharynx, bronchi  Relaxed smooth muscles in bronchi and bronchioles  Decreased airway resistance  Bronchodilation

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Indications: Respiratory (cont’d) Respiratory drugs are used to treat:  Exercise-induced bronchospasms  Chronic bronchitis  Asthma  Chronic obstructive pulmonary disease

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Indications: Gastrointestinal  PSNS controls gastric secretions and smooth muscles that produce gastric motility  Blockade of PSNS results in:  Decreased secretions  Relaxation of smooth muscle  Decreased GI motility and peristalsis

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Indications: Gastrointestinal (cont’d) Gastrointestinal drugs are used to treat:  Irritable bowel disease  GI hypersecretory states

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Indications: Genitourinary  Reflex neurogenic bladder  Incontinence

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Indications  Acute pancreatitis (reduces gastric and pancreatic secretions)  Preoperatively: to reduce salivary secretions

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Adverse Effects Body SystemAdverse Effects CardiovascularIncreased heart rate, dysrhythmias CNSCNS excitation, restlessness, irritability, disorientation, hallucinations, delirium

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Adverse Effects (cont’d) Body SystemAdverse Effects EyeDilated pupils, decreased visual accommodation, increased intraocular pressure GastrointestinalDecreased salivation, decreased gastric secretions, decreased motility

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Adverse Effects (cont’d) Body SystemAdverse Effects GenitourinaryUrinary retention GlandularDecreased sweating RespiratoryDecreased bronchial secretions

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Interactions  Antihistamines, phenothiazines, tricyclic antidepressants, MAOIs  When given with cholinergic blocking drugs, cause additive cholinergic effects, resulting in increased effects

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Nursing Implications  Keep in mind that these drugs will block the action of ACh in the PSNS  Assess for allergies, presence of BPH, glaucoma, tachycardia, MI, HF, hiatal hernia, and GI or GU obstruction  Perform baseline assessment of vital signs and systems overview

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Nursing Implications (cont’d)  Medications should be taken exactly as prescribed to have the maximum therapeutic effect  Overdosing can cause life-threatening problems  Blurred vision may cause problems with driving or operating machinery

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Nursing Implications (cont’d)  Patients may experience sensitivity to light and may want to wear dark glasses or sunglasses  When giving ophthalmic solutions, apply pressure to the inner canthus to prevent systemic absorption

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Nursing Implications (cont’d)  Dry mouth may occur; can be handled by chewing gum, frequent mouth care, and hard candy  Check with physician before taking any other medication, including OTC medications  Antidote for atropine overdose is physostigmine

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Nursing Implications (cont’d)  Anticholinergics taken by the elderly patient may lead to higher risk for heatstroke due to effects on heat- regulating mechanisms  Teach patients to limit physical exertion and avoid high temperatures and strenuous exercise  Emphasize the importance of adequate fluid and salt intake

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Nursing Implications (cont’d) Patients should report the following to their physician: urinary hesitancy and/or retention, constipation, palpitations, tremors, confusion, sedation or amnesia, excessive dry mouth (especially if they have chronic lung infections or disease), or fever

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Nursing Implications (cont’d) Monitor for therapeutic effects  For patients with Parkinson’s disease: fewer tremors and decreased salivation and drooling  For urologic problems: improved urinary patterns, less hypermotility, increased time between voiding Monitor for adverse effects